GlassScriptPhysician profile
Duncan Jackson
NPI 1871277749
$694.27
in general payments reported to CMS, 2019-2025
17 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $384 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $155.23 | 2024 | Farxiga |
| Novo Nordisk INC | $110.11 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $49.64 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $49.10 | 2025 | Journavx |
| Novartis Pharmaceuticals Corporation | $45.34 | 2024-2025 | |
| Sanofi Pasteur INC. | $44.30 | 2025 | |
| Exact Sciences Corporation | $37.17 | 2025 | The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $28.68 | 2025 | Zepbound, Mounjaro |
| Abbvie INC. | $28.01 | 2025 | Dalvance, Avycaz |
| Glaxosmithkline, LLC. | $25.09 | 2024 | Arexvy |
| Merck Sharp & Dohme LLC | $24.19 | 2025 | Enflonsia |
| Alexion Pharmaceuticals, INC. | $21.35 | 2024 | Strensiq |
| Amgen INC. | $17.00 | 2024 | |
| Cvrx, INC. | $15.89 | 2025 | Barostim Neo System |
| Shionogi INC | $15.12 | 2025 | Fetroja |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.75 | 2024 | (Ck7) Extended Holter |
| Pfizer INC. | $13.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duncan Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.